A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

NCT05624554 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions

DRUG: Nemtabrutinib
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Bendamustine
BIOLOGICAL: Rituximab
BIOLOGICAL: Truxima
BIOLOGICAL: Ruxience
BIOLOGICAL: Riabni

Sponsor

Merck Sharp & Dohme LLC